Literature DB >> 9062481

Prostate-specific antigen in female serum, a potential new marker of androgen excess.

D N Melegos1, H Yu, M Ashok, C Wang, F Stanczyk, E P Diamandis.   

Abstract

Prostate-specific antigen (PSA) is present at very low concentrations in female serum, but it can now be measured with highly sensitive immunoassays. We have found that in female tissues the PSA gene is regulated by steroid hormones through the action of steroid hormone receptors. Thus, we examined whether female serum PSA is associated with hyperandrogenic states. Serum PSA levels were compared between 22 hirsute women with a Ferriman-Gallwey score higher than 8 and 50 women without hirsutism. The results show that PSA levels were higher in hirsute women in comparison with controls. In hirsute women, levels of PSA and 3 alpha-androstanediol glucuronide (3 alpha-AG), a specific metabolite of androgen action, showed a significant positive correlation, whereas PSA and 3 alpha-AG showed a significant negative correlation with patient age. Receiver operating characteristic (ROC) analysis revealed that 3 alpha-AG was a slightly better marker of androgen excess than PSA. We conclude that female serum PSA may be a new biochemical marker of androgen action in females.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9062481     DOI: 10.1210/jcem.82.3.3792

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  17 in total

1.  Is Serum Prostate-specific Antigen a Diagnostic Marker for Benign and Malignant Breast Tumors in Women.

Authors:  Seyed Hasan Emami Razavi; Mahsa Ghajarzadeh; Alireza Abdollahi; Ludmila Taran; Saeed Shoar; Ramesh Omranipour
Journal:  Maedica (Buchar)       Date:  2015-06

2.  Serum total PSA and free PSA in breast tumors.

Authors:  Prakruti Dash; Sanghamitra Pati; Manaswini Mangaraj; Pratima Kumari Sahu; Prakash Chandra Mohapatra
Journal:  Indian J Clin Biochem       Date:  2011-02-04

3.  Serum prostate-specific antigen concentration is increased in acromegalic women.

Authors:  L Manetti; I Lupi; M Genovesi; L Morselli; L Grasso; C Nencetti; M Gasperi; F Bogazzi; L Bartalena; E Martino
Journal:  J Endocrinol Invest       Date:  2004 Jul-Aug       Impact factor: 4.256

4.  Serum PSA levels are not affected by the menstrual cycle or the menopause, but are increased in subjects with polycystic ovary syndrome.

Authors:  A Burelli; R Cionini; E Rinaldi; E Benelli; E Fiore; D Canale; W Bencivelli; C Nencetti; A Pinchera; E Pucci
Journal:  J Endocrinol Invest       Date:  2006-04       Impact factor: 4.256

Review 5.  Reconnoitring the status of prostate specific antigen and its role in women.

Authors:  Prakruti Dash
Journal:  Indian J Clin Biochem       Date:  2014-06-22

6.  A Study on Omentin-1 and Prostate Specific Antigen in Women on Treatment for Polycystic Ovary Syndrome.

Authors:  Anbalagan Anithasri; Palghat Harihara Ananthanarayanan; P Veena
Journal:  Indian J Clin Biochem       Date:  2017-12-11

7.  Diagnostic value of prostatic specific antigen in hirsute women.

Authors:  S Güllü; R Emral; M Asik; M Cesur; V Tonyukuk
Journal:  J Endocrinol Invest       Date:  2003-12       Impact factor: 4.256

8.  Serum prostate specific antigen levels in women with polycystic ovary syndrome and the effect of flutamide+desogestrel/ethinyl estradiol combination.

Authors:  M Bahceci; M Bilge; A Tuzcu; S Tuzcu; S Bahceci
Journal:  J Endocrinol Invest       Date:  2004-04       Impact factor: 4.256

9.  Prostate-specific antigen is increased in female patients with Cushing's disease.

Authors:  L Manetti; I Lupi; F Bogazzi; G Pellegrini; A Precisi; L Grasso; C Nencetti; M Gasperi; E Martino
Journal:  J Endocrinol Invest       Date:  2002-10       Impact factor: 4.256

10.  Diagnostic value of prostate-specific antigen (PSA) and free prostate specific antigen (fPSA) in women with ovulatory and anovulatory polycystic ovary syndrome.

Authors:  Kubilay UKINC; Halil Onder Ersoz; Cihangir Erem; Arif Bayram Hacihasanoglu
Journal:  Endocrine       Date:  2008-11-14       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.